Coronavirus Disease 2019
📧 Sign up to get email alerts when something new happens for Coronavirus Disease 2019.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2022-10-19EMA recommends approval of second adapted Spikevax vaccine
EMA recommends approval of a second adapted Spikevax vaccine, expanding options for booster protection against evolving SARS-CoV-2 variants.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure [Phase 2, Phase 3]
Clinical trial update for Dociparstat in adults with severe COVID-19 at high risk of respiratory failure shows termination across Phase 2/3 …
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating inhaled interferon α2b for treating COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis [Phase 2]
A Phase 2 clinical trial assessing neurorehabilitation and recovery related to COVID-19 (NeuroCovid Rehab) completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Losartan for Patients With COVID-19 Requiring Hospitalization [Phase 2]
A Phase 2 clinical trial evaluating losartan for hospitalized COVID-19 patients has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) [Phase 2]
Phase 2 trial update for a recombinant COVID-19 vaccine produced in Sf9 cells has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 [Phase 1, Phase 2]
Clinical trial update for CYNK-001 natural killer cell infusions in adults with COVID-19, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) [Phase 3]
Phase 3 trial evaluating how the immune system affects response to COVID-19 vaccination in allogeneic stem cell recipients.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities [Phase 3]
Phase 3 trial of the SARS-CoV-2 mRNA vaccine CVnCoV in adults with comorbidities was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: SOLIDARITY Finland Plus Long-COVID [Phase 4]
Phase 4 clinical trial update for SOLIDARITY Finland Plus Long-COVID is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19) [Phase 2]
Phase 2 clinical trial assessing the efficacy and safety of Prothione capsules for mild to moderate COVID-19 has been completed.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans [Phase 3]
Phase 3 clinical trial of TY027 for COVID-19 has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients [Phase 3]
Phase 3 trial evaluating favipiravir for moderate to severe COVID-19 was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease [Phase 4]
Phase 4 trial update evaluating angiotensin receptor blockers for COVID-19 outcomes has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Fostamatinib for Hospitalized Adults With COVID-19 [Phase 2]
Phase 2 trial update on fostamatinib for hospitalized adults with COVID-19; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell) [Phase 3]
A Phase 3 clinical trial update for an immune program of a recombinant COVID-19 vaccine (CHO cell) by Anhui Zhifei Longcom Biologic Pharmacy…
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection [Phase 2, Phase 3]
Phase 2/3 clinical trial update for NA-831 (atazanavir and dexamethasone) in COVID-19 infection; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) [Phase 2]
Phase 2 trial assessing CSL312 for adults with COVID-19 has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Efficacy of Adaptogens in Patients With Long COVID-19 [Phase 2, Phase 3]
Phase 2/3 trial update evaluating adaptogens for long COVID-19; completed status reported.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19 [Phase 2]
Phase 2 proof-of-principle trial evaluating safety, pharmacokinetics, viral shedding, and efficacy of Pentarlandir UPPTA for early COVID-19.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 [Phase 1, Phase 2]
A double-blind, placebo-controlled Phase 1/2 trial evaluated the tolerability, safety, and immunogenicity of CoviVac, an inactivated whole v…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) [Phase 1]
Phase 1 trial update evaluating N-Acetyl Glucosamine as a therapeutic intervention for COVID-19 has been completed with results posted.
-
EMA guidance · 2021-10-27EMA working on COVID-19 during closure on 1 and 2 November 2021
EMA outlines how it will work on COVID-19-related matters during its closure on 1 and 2 November 2021, including postponement of non-urgent …
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells) [Phase 3]
Phase 3 trial update evaluating consistency and non-inferiority bridging between batches of a recombinant CHO cell-based COVID-19 vaccine.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine [Phase 2]
Phase 2 trial update on hydroxychloroquine for prevention and treatment of COVID-19 (SARS-CoV-2) was terminated; results posted in 2021.